Diaz, P.I.; Hong, B.-Y.; Dupuy, A.K.; Choquette, L.; Thompson, A.; Salner, A.L.; Schauer, P.K.; Hegde, U.; Burleson, J.A.; Strausbaugh, L.D.;
et al. Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy. J. Fungi 2019, 5, 49.
https://doi.org/10.3390/jof5020049
AMA Style
Diaz PI, Hong B-Y, Dupuy AK, Choquette L, Thompson A, Salner AL, Schauer PK, Hegde U, Burleson JA, Strausbaugh LD,
et al. Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy. Journal of Fungi. 2019; 5(2):49.
https://doi.org/10.3390/jof5020049
Chicago/Turabian Style
Diaz, Patricia I., Bo-Young Hong, Amanda K. Dupuy, Linda Choquette, Angela Thompson, Andrew L. Salner, Peter K. Schauer, Upendra Hegde, Joseph A. Burleson, Linda D. Strausbaugh,
and et al. 2019. "Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy" Journal of Fungi 5, no. 2: 49.
https://doi.org/10.3390/jof5020049
APA Style
Diaz, P. I., Hong, B.-Y., Dupuy, A. K., Choquette, L., Thompson, A., Salner, A. L., Schauer, P. K., Hegde, U., Burleson, J. A., Strausbaugh, L. D., Peterson, D. E., & Dongari-Bagtzoglou, A.
(2019). Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy. Journal of Fungi, 5(2), 49.
https://doi.org/10.3390/jof5020049